Disseminated strongyloidiasis in an immunocompetent male: A Case Report.
Adult
Anemia
/ diagnosis
Antiparasitic Agents
/ therapeutic use
Ascites
/ diagnostic imaging
Blood Transfusion
Diet, High-Protein
Duodenum
/ pathology
Endocarditis
/ diagnosis
Fluid Therapy
Hematinics
/ therapeutic use
Humans
Hypoalbuminemia
/ diagnosis
Immunocompetence
Immunoglobulin E
/ immunology
Ivermectin
/ therapeutic use
Male
Mitral Valve Insufficiency
/ diagnostic imaging
Pleural Effusion
/ diagnostic imaging
Strongyloidiasis
/ diagnosis
Tomography, X-Ray Computed
Tricuspid Valve Insufficiency
/ diagnostic imaging
Ultrasonography
Strongyloidesstercoralis, Disseminated strongyloidiasis, Immunocompetent host.
Journal
JPMA. The Journal of the Pakistan Medical Association
ISSN: 0030-9982
Titre abrégé: J Pak Med Assoc
Pays: Pakistan
ID NLM: 7501162
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
entrez:
21
5
2019
pubmed:
21
5
2019
medline:
19
12
2019
Statut:
ppublish
Résumé
Strongyloidiasis is a human parasitic disease caused by infection of Strongyloidesstercoralis. It can manifest from asymptomatic eosinophilia in an immunocompetent host and disseminate the disease in the immunocompromised ones. The inconsistency of eosinophilia and low sensitivity of a standard microscopic stool examination makes it difficult to diagnose the disease. We report a case of chronic strongyloidiasis who, despite being immunocompetent, developed dissemination. The patient was a 30-years-old male who presented with diarrhoea, vomiting, high-grade fever and dyspnoea. On examination, he was pale, oedematous and had ascites with systolic murmurs in tricuspid area. After a fullworkup for differentials, biopsy confirmed the diagnosis of strongyloidiasis. Echocardiogram revealed vegetations on mitral and tricuspid valves and regurgitation through the valves, which confirmed dissemination to endocardium. A course of Ivermectin 9 mg daily for two weeks eradicated the infection in time. In conclusion, awareness for physicians and the use of various diagnostic methods like serology, endoscopy and biopsy should be considered for high risk patients.
Substances chimiques
Antiparasitic Agents
0
Hematinics
0
Immunoglobulin E
37341-29-0
Ivermectin
70288-86-7
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM